Loss of PTPN2 in intestinal epithelial cells promotes the secretion of inflammatory cytokines and dysfunction of the intestinal barrier, which are vital factors in MASLD pathogenesis. This evidence concerns the gene PTPN2 and metabolic dysfunction-associated steatotic liver disease.